CAS: 2118356-96-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PROTAC CDK9 Degrader-1 REF: IN-DA01EO8ZCAS: 2118356-96-8 | 99% | To inquire | Tue 07 Jan 25 |
 | PROTAC CDK9 Degrader-1 REF: TM-T5438CAS: 2118356-96-8 | 98% | 141.00 €~1,218.00 € | Wed 08 Jan 25 |
 | PROTAC CDK9 Degrader-1 REF: 3D-TJD35696CAS: 2118356-96-8 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01EO8Z
| 5mg | 134.00 € | ||
| 25mg | 322.00 € | ||
| 50mg | 513.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
PROTAC CDK9 Degrader-1
CAS:2118356-96-8
PROTAC CDK9 Degrader-1 is a selective PROTAC-based CDK9 degrader, composed of a Cereblon ligand and …
Formula:
C33H35N5O7
Purity:
98%
Color and Shape:
Solid
Molecular weight:
613.66
Ref: TM-T5438
| 1mg | 141.00 € | ||
| 5mg | 349.00 € | ||
| 10mg | 546.00 € | ||
| 25mg | 886.00 € | ||
| 50mg | 1,218.00 € | ||
| 1mL*10mM (DMSO) | 470.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
PROTAC CDK9 Degrader-1
CAS:2118356-96-8
PROTAC CDK9 Degrader-1 is a combination therapy that includes two different types of drugs. One …
Formula:
C33H35N5O7
Purity:
Min. 95%
Molecular weight:
613.66 g/mol
Ref: 3D-TJD35696
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
